Jenkins Annalisa
SEC insider (Form 3/4/5 filer). CIK 0001639481. Director at Skye Bioscience, Inc. (SKYE) and 2 other issuers. 9 reported Form 4/5 transactions since Sep 2024; latest on Mar 31, 2026. Located in SAN DIEGO, CA.
Companies Jenkins Annalisa has filed insider reports for
- Skye Bioscience, Inc. (SKYE): Director
- Mereo BioPharma Group plc (MREO): Director
- COMPASS Pathways plc (CMPS): Director
Jenkins Annalisa
CIK: 0001639481
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Mar 31, 2026SKYE
Skye Bioscience, Inc.
AwardDirectStock Option (Right to Buy)
75K shares- - Feb 26, 2026MREO
Mereo BioPharma Group plc
AwardDirectShare Options (Right to buy)
66K shares- - Feb 26, 2026MREO
Mereo BioPharma Group plc
AwardDirectDeferred Restricted Stock Units
106.8K shares- - Feb 6, 2026SKYE
Skye Bioscience, Inc.
AwardDirectStock Option (Right to Buy)
35K shares- - Jun 12, 2025CMPS
COMPASS Pathways plc
AwardDirectShare Option (Right to Buy)
26K shares- - Feb 24, 2025SKYE
Skye Bioscience, Inc.
AwardDirectStock Option (Right to Buy)
35K shares- - Feb 5, 2025MREO
Mereo BioPharma Group plc
AwardDirectDeferred Restricted Stock Units
15.2K shares- - Feb 5, 2025MREO
Mereo BioPharma Group plc
AwardDirectShare Options (Right to buy)
55K shares- - Oct 28, 2024SKYE
Skye Bioscience, Inc.
AwardDirectStock Option (Right to Buy)
70K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 31, 2026 |  SKYE Skye Bioscience, Inc. | Award Stock Option (Right to Buy) | 75,000 | - | - | Direct |
| Feb 26, 2026 |  MREO Mereo BioPharma Group plc | Award Share Options (Right to buy) | 66,000 | - | - | Direct |
| Feb 26, 2026 | MREO Mereo BioPharma Group plc | Award Deferred Restricted Stock Units | 106,848 | - | - | Direct |
| Feb 6, 2026 | SKYE Skye Bioscience, Inc. | Award Stock Option (Right to Buy) | 35,000 | - | - | Direct |
| Jun 12, 2025 |  CMPS COMPASS Pathways plc | Award Share Option (Right to Buy) | 26,000 | - | - | Direct |
| Feb 24, 2025 | SKYE Skye Bioscience, Inc. | Award Stock Option (Right to Buy) | 35,000 | - | - | Direct |
| Feb 5, 2025 | MREO Mereo BioPharma Group plc | Award Deferred Restricted Stock Units | 15,243 | - | - | Direct |
| Feb 5, 2025 | MREO Mereo BioPharma Group plc | Award Share Options (Right to buy) | 55,000 | - | - | Direct |
| Oct 28, 2024 | SKYE Skye Bioscience, Inc. | Award Stock Option (Right to Buy) | 70,000 | - | - | Direct |
1-9 of 9 transactions